PRESS RELEASES
Pushing mRNA vaccine development timelines to new speeds
February 6, 20256 February 2025; OSLO; PARIS: Scientists in Paris are set to advance new technology that could streamline the production of …
▶
▶
PRESS RELEASES
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences
February 5, 2025CAIRO, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a …
▶
▶
PRESS RELEASES
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
October 17, 2024Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, …
▶
▶
PRESS RELEASES
DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference
May 22, 2023Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos …
▶
▶
PRESS RELEASES
DNA Script Strengthens Its Management Team with the Appointment of Bruno Poddevin as Senior Vice President of Business and Corporate Development
November 9, 2022Poddevin joins DNA Script in a year of immense growth in hiring, financing, commercialization and collaborations. DNA Script, a world …
▶
▶
PRESS RELEASES
DNA Script Expands Leadership Team with Appointment of Madoo Varma as Vice President of Business Development
October 14, 2022DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has expanded and strengthened its leadership …
▶
▶
PRESS RELEASES
DNA Script Expands Distributorships to Middle East to Meet Growing Demand for Same-day Enzymatic DNA Synthesis
October 12, 2022Company partners with leading distributors in the Gulf region and Israel as well as expands Asia Pacific coverage to Japan …
▶
▶
PRESS RELEASES
DNA Script Wins the Grand Prize Trophy at the 2022 French Future Unicorns Ceremony
September 16, 2022DNA Script selected from 250 French companies to receive top award DNA Script, a world leader in Enzymatic DNA Synthesis …
▶
▶
PRESS RELEASES
French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats
June 28, 2022In response to strong results, the Agency has extended DNA Script’s contract DNA Script, a world leader in Enzymatic DNA …
▶
▶
PRESS RELEASES
DNA Script Enables Same-day q/dPCR from Design to Results with Launch of Next-generation SYNTAX Kits at AGBT
June 6, 2022Next-generation SYNTAX kits, now supporting the synthesis of probes labeled with fluorophores, quenchers, or biotin, provide the fastest solution for …
▶
▶
PRESS RELEASES
DNA Script Appoints Chris Barbazette as Chief Commercial Officer
May 10, 2022Industry veteran brings decades of experience building and scaling successful commercial strategies for leading life science and diagnostic companies DNA …
▶
▶
PRESS RELEASES
DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology
April 12, 2022Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with …
▶
▶
PRESS RELEASES
DNA Script Partners with Asia-Pacific Distributors as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis
April 5, 2022Company expands worldwide footprint to China, Hong Kong, India, Singapore, South Korea and Taiwan for sales, distribution, and support of …
▶
▶
AWARDS, PRESS RELEASES
DNA Script Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
March 8, 2022Company’s enzymatic DNA printing on demand technology recognized as no. 3 in the biotech category. DNA Script, a world leader …
▶
▶
PRESS RELEASES
DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies
February 2, 2022Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era …
▶
▶
